ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,293Medicare Part D Prescriptions Filled, Including Refills

Rank: 723 out of 3035

$487K Total Retail Price of All Prescriptions

Rank: 1125 out of 3035

583 Patients Receiving at Least One Drug in Part D
83% Patients 65 Years and Older
21% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Texas
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

16% of this provider’s 583 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $68 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Texas
SIMVASTATIN 501 443 102 1 4
LEVOTHYROXINE SODIUM 479 418 93 2 1
LISINOPRIL 478 404 113 3 3
OMEPRAZOLE 293 237 72 4 8
AMLODIPINE BESYLATE 283 231 81 5 2
FUROSEMIDE 281 264 83 6 7
HYDROCODONE-ACETAMINOPHEN 260 189 84 S3 7 5
METFORMIN HCL 246 194 46 8 9
METOPROLOL TARTRATE 236 214 59 9 10
CLOPIDOGREL 212 196 59 10 18
HYDROCHLOROTHIAZIDE 199 157 40 11 16
TRAMADOL HCL 188 162 64 12 17
WARFARIN SODIUM 180 149 26 13 25
ATORVASTATIN CALCIUM 137 107 38 14 6
CARVEDILOL 131 106 35 15 21
GABAPENTIN 130 112 36 16 12
ISOSORBIDE MONONITRATE ER 129 124* 31 17 61
GLIPIZIDE 129 91 24 17 50
ALPRAZOLAM 122 108 37 B 19 19
POTASSIUM CHLORIDE 120 100 40 20 15
AMOXICILLIN 110 82 87 21 121
LISINOPRIL-HYDROCHLOROTHIAZIDE 105 89 25 22 34
FLUTICASONE PROPIONATE 101 79 43 23 33
ALENDRONATE SODIUM 98 98 24 24 30
PANTOPRAZOLE SODIUM 98 93* 29 24 24
METOPROLOL SUCCINATE 97 84 22 26 13
LOSARTAN POTASSIUM 96 96 17 27 14
TRIAMTERENE-HCTZ 92 87* 25 28 68
ALLOPURINOL 81 76* 15 29 38
LORAZEPAM 80 65 15 B 30 47
ZOLPIDEM TARTRATE 77 59 15 31 23
PRAVASTATIN SODIUM 76 45 16 32 11
CIPROFLOXACIN HCL 76 60 57 32 51
SERTRALINE HCL 75 70* 18 34 26
LOVASTATIN 74 55 18 35 52
TRAZODONE HCL 73 39 13 36 40
METHYLPREDNISOLONE 73 57 59 36 92
CITALOPRAM HBR 73 59 15 36 29
ATENOLOL 72 67* 20 39 32
NEXIUM 67 56 15 40 20
CRESTOR 67 62* 17 40 22
DIOVAN 66 66 11 42 36
PREDNISONE 65 45 27 43 45
LEVOFLOXACIN 61 50 57 44 55
PROAIR HFA 58 24 21 45 65
GLIMEPIRIDE 58 <11 <11 45 37
DIGOX 57 52* 19 47 100
CLONIDINE HCL 55 50* 25 48 48
NAPROXEN 54 49* 32 49 84
SULFAMETHOXAZOLE-TRIMETHOPRIM 52 47* 39 50 88
FAMOTIDINE* 52 <11 <11 50 76
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 13, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.